Newsweek - National News, World News, Health, Technology, Entertainment and more... | Newsweek.com
SPONSORED BY
  • Rep Takes Issue With FactCheck Article

    Editors | Feb 27, 2009 03:18 PM
    A recent article by our partner FactCheck.org on health care provisions in the stimulus package generated a healthy amount of discussion. Among the letters we received was this one from Rep. John Shadegg of Arizona: Newsweek recently republished a piece... More
  • We Appreciate the Mention, Congressman. Now About Reading the Story…

    Daniel Stone | Feb 16, 2009 09:00 AM
    We here at Newsweek love when we get people into vigorous and thoughtful debates. Particularly when they're inspired to do so by something we've published. So you can imagine how we felt to see this week's cover story about America's increasingly socialist approach to broad problems (under the headline asserting We Are All Socialists Now) get a cameo in the seat of power. It happened on the floor of the U.S. House of Representatives, during an exchange between Rep. Todd Akin (R-Missouri) and Rep. John Carter (R-Texas), who used our publication as a prop to oppose the president's stimulus bill.

    But it quickly became clear that both lawmakers had somehow missed the point of the article (which was to say America's fierce borrow-and-spend capitalist policies over the past decade have left us looking more, not less, like France). In fact, it soon seemed that neither had actually read it.

    Akin disagreed with our cover headline (a riff, it should be noted, on Richard Nixon's 1971 assertion 'We're all Keynesians now'), but the shots Akin took at what he assumed was our foundation were something we just couldn't let squeak by. So we collected some points we wanted to correct -- for the record:

    "Now what we're talking about here [referring to the stimulus bill] is socialism. We're going to take, after the economy takes a hit, we're going to spend money like mad. We're not going to create jobs. We're just going to slop it around and hope somehow it is going to make the economy better. And the facts of history are that it doesn't work… There was an interesting cover on Newsweek. It says, we are all socialists. I think there's an awful lot of people in…my district that are thankful for [Carter's] common sense and willingness to just basically state it the way it is." - Rep. Akin

    Well, to start our story didn't address any single piece of legislation, certainly not the stimulus bill debated over the past few weeks. In fact, that was the point. Editor Jon Meacham and Editor-at-Large Evan Thomas argue that we find ourselves all to be socialists because of loose regulatory policies that led to massive borrowing and spending, leaving us in our current precarious spot where more borrowing and spending seem to be the only solution.

    "Sometimes when you hear the term "socialism,"'...young people really don't know what you're saying. But they do know people interfering with their lives. Because quite frankly, whether they were going to college and paying exorbitant fees to go to school, or whatever it is, as they have moved into the workforce, they see that the government is available to interfere with their lives. And the real issue here is we're growing government and we're giving government the ability to interfere more and more in the lives of people." -Rep. Carter
    "So when the economy gets better, we have more money to spend. And that is what has always made America great. It's because there are certain basic true principles that are not smoke and mirrors. It's not a whole lot of government redistribution of wealth, and not everybody is a socialist, in spite of what the cover of Newsweek wants to tell us." -Rep. Akin

    Our story (the deep content inside the cover the congressmen seem so fixated by) offers no such individual prescription. There aren't masked socialists hiding among us eager to take over the government. No, we're all closer to being socialists because of the manner in which our government has decided to respond to unstable markets and industries over the past year. The solution, we can all agree, is a stimulated economy. But, as our story states, "since neither consumers not business is likely to do it, government will have to stimulate the economy."

    "It's not the job of the government to take everybody's property away from them and to slop it around and redistribute it. That is socialism. This idea was tried by the Soviet Union. The government is going to provide you with a job and with health care and with food, and the government is going to give you your education. That idea died in the dustbin of history when the Soviet Union collapsed." -Rep. Akin

    That is indeed what socialism is, at its most extreme. And yes, history has proven it doesn't work so well in practice as in theory. But as Michael Freedman notes in his piece accompanying the cover story, the emerging trend is rather toward "what could be called a European model of governance, regulation and paternalism." Or perhaps what really spooks Rep. Akin is the picture Freedman lays out later: "Think about it, and it's very easy to imagine a chorus of former American individualists demanding cushy French-style pensions and free British-style health care if their private stock funds fail to recover and unemployment inches upward toward 10 percent and remains there." If, that is, Rep. Akin actually read the story and was thinking of the future.

    Jon and Evan figured that some members in congress would disagree and even dismiss our assertions. And that's okay. But the meat of the argument spoke directly to men like Akin and Carter -- those in government who continue to see the challenge of the future in the context of the past. They write: "If we fail to acknowledge the reality of the growing role of government in the economy, insisting instead on fighting 21st-century wars with 20th-century terms and tactics, then we are doomed to a fractious and unedifying debate. The sooner we understand where we truly stand, the sooner we can think more clearly about how to use government in today's world."

    We just wanted to clear that up.
    More
  • Advertisement
  • Challenging Oprah (Again) on Hormone Therapy

    Kurt Soller | Feb 12, 2009 04:09 PM

    Early this week, our two resident menopause experts, Pat Wingert and Barbara Kantrowitz, took issue with an Oprah special on Hormone Therapy. In the episode, the television host praised her guest, Suzanne Somers, for a health plan that places heavy emphasis on taking too many hormones. Here's the money quote, from one doctor: “Oprah is the most influential woman in the world, and I don’t think she comprehends the amount of damage she has done to women’s health.”

    In summing up their argument, Pat and Barbara pointed to six things the that Oprah and Somers did wrong: They downplayed the risks of Hormone Therapy. They failed to discuss cancer. Meanwhile, they encouraged a false fountain of youth. The television show prescribed a one-treatment-fits-all philosophy, while blaming menopause for everything a woman may be going through. Overall, they say the episode lacked clarity when discussing the issue.

    Many readers agreed, asking: “Why is Suzanne Somers on stage being lauded as an expert as the doctors sitting in the front row added very little to the conversation?”

    But much of the commentary completely dismissed our two writers. “Talking with Kantrowitz and Wingert about [hormone therapy] is like talking to a Republican senator about the economic stimulus plan,” wrote one snarky reader. Others argued that they have found doctors that agree with Somers and that our two writers present a completely one-sided argument.

    That’s the start of what’s developed into a series of offensive comments, which have culminated in accusing the writers of being on the take from drug companies. “The article's authors were clearly coached and prompted by the pharmaceutical industry to sing its song-and-dance routine to attack anything that threatens their bottom line,” suggested one reader. “I'm shocked that Newsweek would allow its editorial integrity to be so transparently hijacked by these phonies who are doing nothing but parroting the drug companies' script, practically word for word.”

    Given those strong – and untrue – accusations, I asked my colleagues to put together a response to the piece, clarifying their points about Hormone Therapy. Here is what Pat submitted:

    We appreciate the fact that this story has generated a lively discussion among readers but would like to offer a couple of clarifications. Some commenters have attempted to explain away the concerns we raised about the safety of compounding-pharmacy-produced bio-identical hormones by accusing us (and/or Newsweek) of being on the take to pharmaceutical companies.

    These accusations are not only offensive but absolutely not true, and we hope readers are skeptical enough to note that not one of these posters has offered a shred of evidence to prove their point. The magazine accepts advertisements from a wide variety of legitimate businesses, including drug companies, but in the more than 20 years Barbara and I have worked for Newsweek, we have never been asked to slant our reporting or writing to benefit an advertiser. Our advertising and editorial departments have always been separate and independent.

    Secondly, there seems to be a lot of confusion about what constitutes a "natural" hormone. Natural hormones are those produced by the human body. Period. Any type of hormone product, including those used in hormone creams, sprays, rings, pills and patches, are synthesized from plants or animal products. That means they are all synthetics, even if they are chemically identical to those produced by the human body.

    Those who insist that all hormones made by drug companies are "synthetics" and those produced by compounding pharmacies are "natural" are creating a false distinction. The same can be said about presumed risk. Since all these products have similar effects on the body, the presumption by the scientific community is that they likely all have the same risks, unless proof emerges to the contrary. So far, we don't have that proof.

    And finally, about the advantage of FDA regulation: No one thinks that the FDA does a perfect job, and we all know that they have made mistakes. But there's no doubt that the FDA safety and efficacy testing saves many lives every year.
    More